Acella Pharmaceuticals recalls

Acella Pharmaceuticals has 16 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 13 May 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls16since 2020

Last 12 months2reported

Class I1063% of total

Ongoing2latest 13 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 1Oct 0 0 0Jan '26 0 0 0Apr 1 0 0Jul 0 0

Severity split

Class I 10 63%Class II 2 13%Class III 4 25%

Why acella pharmaceuticals is recalled

Product types

Brands

Np Thyroid 151063%
Phenytoin Sodium213%
Sodium Sulfacetamide 10 Sulfur 5 Cleanser16%
Doxycycline16%
Naproxen16%

By year

202616%
202516%
202416%
2022319%
2021531%
2020531%

Ongoing acella pharmaceuticals recalls

2 active

Reported	Class	Recall	Company	Reason	Where
13 May 2026Drug	CLASS II	Naproxen Oral Suspension, USP, 125 mg recalled by Acella PharmaceuticalsNaproxen	Acella Pharmaceuticals	Lead & Heavy Metals	Nationwide
15 Oct 2025Drug	CLASS II	Doxycycline Hyclate Tablets, USP 100 mg* recalledDoxycycline	Acella Pharmaceuticals	Potency & Assay	Nationwide

All acella pharmaceuticals recalls, newest first

16 total

Reported	Class	Recall	Company	Reason	Where
13 May 2026Drug	CLASS II	Naproxen Oral Suspension, USP, 125 mg recalled by Acella PharmaceuticalsNaproxen	Acella Pharmaceuticals	Lead & Heavy Metals	Nationwide
15 Oct 2025Drug	CLASS II	Doxycycline Hyclate Tablets, USP 100 mg* recalledDoxycycline	Acella Pharmaceuticals	Potency & Assay	Nationwide
15 May 2024Drug	CLASS III	Sodium Sulfacetamide 10% - Sulfur 5% Cleanser recalledSodium Sulfacetamide 10 Sulfur 5 Cleanser	Acella Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2022Drug	CLASS III	Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads recalled	Acella Pharmaceuticals	Potency & Assay	Nationwide
30 Nov 2022Drug	CLASS III	Phenytoin Sodium Injection, USP 100 mg recalledPhenytoin Sodium	Acella Pharmaceuticals	Packaging Defects	Nationwide
30 Nov 2022Drug	CLASS III	Phenytoin Sodium Injection, USP, 250 mg recalledPhenytoin Sodium	Acella Pharmaceuticals	Packaging Defects	Nationwide
2 Jun 2021Drug	CLASS I	NP Thyroid, USP 1/4 grain (15 mg) recalled by Acella PharmaceuticalsNp Thyroid 15	Acella Pharmaceuticals	Potency & Assay	Nationwide
2 Jun 2021Drug	CLASS I	NP Thyroid, USP 1&1/2 grain (90 mg) recalled by Acella PharmaceuticalsNp Thyroid 15	Acella Pharmaceuticals	Potency & Assay	Nationwide
2 Jun 2021Drug	CLASS I	NP Thyroid, USP 1 grain (60 mg) recalled by Acella PharmaceuticalsNp Thyroid 15	Acella Pharmaceuticals	Potency & Assay	Nationwide
2 Jun 2021Drug	CLASS I	NP Thyroid, USP 1/2 grain (30 mg) recalled by Acella PharmaceuticalsNp Thyroid 15	Acella Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.